AntineoplasticsDrug resistance to osimertinib and savolitinib and diarrhoea: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1643卷 / 1期

关键词：

D O I：

10.1007/s40278-017-27503-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：30 / 30

相关论文

共 50 条

[21] OsimertinibDevelopment of osimertinib resistance: case report
[J]. Reactions Weekly, 2017, 1659 (1) : 225 - 225
[22] OsimertinibAcquired resistance to osimertinib: case report
[J]. Reactions Weekly, 2017, 1680 (1) : 270 - 270
[23] OsimertinibDrug resistance to osimertinib: case report
[J]. Reactions Weekly, 2017, 1659 (1) : 226 - 226
[24] AntineoplasticsDrug allergy: case report
[J]. Reactions Weekly, 2022, 1899 (1) : 45 - 45
[25] AntiretroviralsDrug resistance and diarrhoea: case report
[J]. Reactions Weekly, 2023, 1944 (1) : 105 - 105
[26] AntineoplasticsDrug resistance, bone marrow suppression and shortness of breath: case report
[J]. Reactions Weekly, 2019, 1778 (1) : 53 - 53
[27] AntineoplasticsDrug hypersensitivity: case report
[J]. Reactions Weekly, 2006, 1100 (1) : 8 - 8
[28] OsimertinibAcquired resistance to osimertinib therapy: case report
[J]. Reactions Weekly, 2018, 1707 (1) : 217 - 217
[29] Osimertinib/gefitinib/erlotinibDevelopment of resistance to osimertinib, gefitinib and erlotinib: case report
[J]. Reactions Weekly, 2017, 1654 (1) : 269 - 269
[30] AntineoplasticsDrug resistance: 8 case reports
[J]. Reactions Weekly, 2020, 1807 (1) : 25 - 25

← 1 2 3 4 5 →